Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and can progress to liver cirrhosis, liver failure or cancer. Currently, nonalcoholic steatohepatitis (NASH ...

Non-alcoholic fatty liver disease (NAFLD) stands as a prominent liver disorder globally, with its incidence surging from 25.26% in 1990–2006 to 38.00% in 2016–2019. NAFLD characterizes the ...

Although fibrosis-4 index and NAFLD fibrosis score did not significantly differ in diagnosing advanced fibrosis in nonalcoholic fatty liver disease, fibrosis-4 may be a better screening tool in ...

NAFLD fibrosis score, FIB-4 increase at similar rate in advanced fibrosis. Add topic to email alerts Receive an email when new articles are posted on .

For example, in the UK Biobank cohort, for each 1-point increase in the NAFLD fibrosis score, the adjusted HR for risk of PAD was 1.40 (95% CI, 1.31-1.50; P < .001).

On the basis of NAFLD-Fibrosis Score (NAFLD-FS), 13 patients had a low probability of liver fibrosis (F0 to F2), 54 had an indeterminate probability, and 22 a high probability of fibrosis (F3 to F4).

Additionally, in the secondary outcomes, we showed that there are surrogates of fatty liver disease including NFS [NAFLD Fibrosis Score], FIB-4, ALT [alanine transaminase], and CAP [controlled ...

Because Mr L presented with a low Fibrosis-4 index score during his initial evaluation, and his VCTE results 10 years later confirmed a lack of disease progression, Dr Tapper indicated that no ...

Obesity and weight gain were independently associated with an increased risk for fibrosis progression in patients with nonalcoholic fatty liver disease (NAFLD), a study found.

In the analysis involving over 1,700 NAFLD patients, the rate of death per 100 person-years was 1.76 among those with cirrhosis (stage F4), as compared to 0.32 for those with stages F0-F2 fibrosis ...